The role of histone post-translational modifications in merkel cell carcinoma
C Mazziotta, C Lanzillotti, R Gafà, A Touzé… - Frontiers in …, 2022 - frontiersin.org
Merkel Cell Carcinoma (MCC) is a rare but highly aggressive form of non–melanoma skin
cancer whose 5-year survival rate is 63%. Merkel cell polyomavirus (MCPyV), a small DNA …
cancer whose 5-year survival rate is 63%. Merkel cell polyomavirus (MCPyV), a small DNA …
Identifying candidates for immunotherapy among patients with non-melanoma skin cancer: a review of the potential predictors of response
E Zelin, CA Maronese, A Dri, L Toffoli, N Di Meo… - Journal of Clinical …, 2022 - mdpi.com
Background: Non-melanoma skin cancer (NMSC) stands as an umbrella term for common
cutaneous malignancies, including basal cell carcinoma (BCC) and cutaneous squamous …
cutaneous malignancies, including basal cell carcinoma (BCC) and cutaneous squamous …
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
Background Merkel cell carcinoma is among the most aggressive and lethal of primary skin
cancers, with a high rate of distant metastasis. Anti-programmed death receptor 1 (anti-PD …
cancers, with a high rate of distant metastasis. Anti-programmed death receptor 1 (anti-PD …
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a …
Background Merkel cell carcinoma (MCC) is an immunogenic but aggressive skin cancer.
Even after complete resection and radiation, relapse rates are high. PD-1 and PD-L1 …
Even after complete resection and radiation, relapse rates are high. PD-1 and PD-L1 …
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024: Featured Updates to the NCCN Guidelines
CD Schmults, R Blitzblau, SZ Aasi, M Alam… - Journal of the National …, 2024 - jnccn.org
The NCCN Guidelines for Merkel Cell Carcinoma (MCC) provide recommendations for
diagnostic workup, clinical stage, and treatment options for patients. The panel meets …
diagnostic workup, clinical stage, and treatment options for patients. The panel meets …
Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options
Merkel cell carcinoma is a rare neuroendocrine carcinoma that typically appears in sun‐
exposed areas of the elderly. It has a poor prognosis and with its incidence projected to …
exposed areas of the elderly. It has a poor prognosis and with its incidence projected to …
Lipid nanoparticles delivering constitutively active STING mRNA to stimulate antitumor immunity
Treating immunosuppressive tumors represents a major challenge in cancer therapies.
Activation of STING signaling has shown remarkable potential to invigorate the …
Activation of STING signaling has shown remarkable potential to invigorate the …
Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma
T Gambichler, S Said, N Abu Rached… - Journal of Cancer …, 2022 - Springer
Purpose We aimed to determine whether the pan-immune-inflammation value (PIV) of
patients with Merkel cell carcinoma (MCC) at primary diagnosis differs from controls and …
patients with Merkel cell carcinoma (MCC) at primary diagnosis differs from controls and …
T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma
UK Hansen, CD Church, AMC Simões… - The Journal of …, 2024 - Am Soc Clin Investig
Merkel cell carcinoma (MCC) is a highly immunogenic skin cancer primarily induced by
Merkel cell polyomavirus, which is driven by the expression of the oncogenic T antigens (T …
Merkel cell polyomavirus, which is driven by the expression of the oncogenic T antigens (T …
Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis
A Glover, Z Zhang, C Shannon-Lowe - Frontiers in immunology, 2023 - frontiersin.org
Myeloid derived suppressor cells (MDSCs) are a heterogenous population of myeloid cells
derived from monocyte and granulocyte precursors. They are pathologically expanded in …
derived from monocyte and granulocyte precursors. They are pathologically expanded in …